Filing Flows › HeartSciences (HSCS) › Q4 FY25
HeartSciences (HSCS) Q4 FY25 earnings results (fourth quarter fiscal 2025)
10-K filed Jul 24, 2025
HeartSciences (HSCS) reported revenue of $4K for the fourth quarter fiscal 2025 (Q4 FY25).
HeartSciences, Q4 FY25: revenue $4K, net loss $2.1M, operating cash flow −$1.6M. The chart follows the revenue to costs, profit and cash.
| Q4 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4K | — | — |
| Operating profit | −$1.9M | — | — |
| Net earnings | −$2.1M | — | — |
| Operating cash flow | −$1.6M | — | — |
What changed
Revenue was $4K in Q4 FY25.
Gross margin was 56.8%. Operating costs exceeded revenue by $1.9M, an operating margin of -44147.1%. The quarter ended with a net loss of $2.1M.
Operating cash flow was −$1.6M. Non-cash charges added back $8K of depreciation and $96K of share-based compensation. Working capital and other items added $400K.
Questions
What was HeartSciences' revenue in the fourth quarter fiscal 2025?
HeartSciences (HSCS) reported revenue of $4K for the fourth quarter fiscal 2025 (Q4 FY25).
Source: HeartSciences 10-K on SEC EDGAR.